Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results, Exceeding or Meeting Full Year 2020 Financial Guidance; Provides Full Year 2021 Financial Guidance

Go back to Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results, Exceeding or Meeting Full Year 2020 Financial Guidance; Provides Full Year 2021 Financial Guidance
IRONWOOD PHARMA-A (NASDAQ: IRWD) Delayed: 4.26 +0.09 (2.16%)
Previous Close $4.17    52 Week High $16.89 
Open $4.27    52 Week Low $7.35 
Day High $4.48    P/E N/A 
Day Low $4.23    EPS $-2.35 
Volume 1,472,951